IDEXX Laboratories, Inc. (IDXX) Stock Price Today
Aura AI Summary
Key Stats
- $44.22BMarket Cap
- 488,131Volume
- HealthSector
- $766.6852W High
- $504.7052W Low
- 47 DaysTypical Hold Time
- $45.12BEnterprise Value
- -Div Yield
- -Trading Activity
Track IDEXX Laboratories, Inc. (IDXX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, IDEXX Laboratories, Inc. has traded between a low of $504.7 and a high of $766.68, highlighting its annual price range. Buy and sell IDEXX Laboratories, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Most Recent News
Stella-Jones executives to present at RBC Capital Markets 2026 Global Industrials Conference
Stella-Jones Inc. announced that its CEO Eric Vachon and CFO Silvana Travaglini will participate in the RBC Capital Markets 2026 Global Industrials Conference in New York on November 16, 2026. The company will hold meetings with institutional investo...

Stella-Jones executives to present at RBC Industrial Products Conference in New York on Nov 16, 2026
Stella-Jones Inc. announced that its CEO Éric Vachon and CFO Silvana Travaglini will attend the RBC Capital Markets 2026 Global Industrial Products Conference in New York on November 16, 2026. They will meet with institutional investors to discuss th...

Copenhagen Airports appoints Sofie Mørck Jarl as new CFO starting March 2027
Copenhagen Airports has named Sofie Mørck Jarl as its new Chief Financial Officer, effective by March 1, 2027. She previously held senior finance roles at Novo Nordisk and brings experience in strategy, financial leadership, and managing large invest...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.